Royal jelly lipophilic fraction induces antiproliferative effects on SH-SY5Y human neuroblastoma cells

  • Authors:
    • Angelo Gismondi
    • Eleonora Trionfera
    • Lorena Canuti
    • Gabriele Di Marco
    • Antonella Canini
  • View Affiliations

  • Published online on: July 24, 2017     https://doi.org/10.3892/or.2017.5851
  • Pages: 1833-1844
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Royal jelly (RJ) is one the most important bee product because it strongly influences the larval development in the hive, including the queen bee. In literature, RJ is known for its antioxidant, immunoregulatory, antifungal, antibiotical, erythropoietic, hypoglycemic, anticholesteremic, antithyroidic, anti-osteoporotic and estrogenic properties. However, it is surprising how rare the scientific evidence about RJ antineoplastic capacity are. That being said, we investigated, for the first time, the in vitro bioactivity of six different RJs on the growth of three different mammalian cell lines: immortalized murine myoblasts (C2C12), human prostate cancer (PC3) and human neuroblastoma (SH-SY5Y). These studies were performed treating the cells with the only lipophilic, or hydrophilic, fraction of the RJs, a scientific approach never performed before. Moreover, chemical and protein profiles of all RJs were finely characterized, in qualitative and quantitative terms, by GC-MS and 1D-SDS-PAGE, respectively, in order to give a complete framework to the research. Despite the deep differences we found in the composition of each sample, unexpectedly, RJs showed comparable or very similar biological effects. In particular, our attention was captured by the extraordinary antiproliferative activity of the lipophilic extract of all RJs against SH-SY5Y cells, suggesting a potential medical application of this bee product to prevent the onset and slow down the growth of human neuroblastoma.
View Figures
View References

Related Articles

Journal Cover

September-2017
Volume 38 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Gismondi A, Trionfera E, Canuti L, Di Marco G and Canini A: Royal jelly lipophilic fraction induces antiproliferative effects on SH-SY5Y human neuroblastoma cells. Oncol Rep 38: 1833-1844, 2017
APA
Gismondi, A., Trionfera, E., Canuti, L., Di Marco, G., & Canini, A. (2017). Royal jelly lipophilic fraction induces antiproliferative effects on SH-SY5Y human neuroblastoma cells. Oncology Reports, 38, 1833-1844. https://doi.org/10.3892/or.2017.5851
MLA
Gismondi, A., Trionfera, E., Canuti, L., Di Marco, G., Canini, A."Royal jelly lipophilic fraction induces antiproliferative effects on SH-SY5Y human neuroblastoma cells". Oncology Reports 38.3 (2017): 1833-1844.
Chicago
Gismondi, A., Trionfera, E., Canuti, L., Di Marco, G., Canini, A."Royal jelly lipophilic fraction induces antiproliferative effects on SH-SY5Y human neuroblastoma cells". Oncology Reports 38, no. 3 (2017): 1833-1844. https://doi.org/10.3892/or.2017.5851